Fearing $10B FCA Loss, Teva Seizes On Kickback Circ. Split
The U.S. Department of Justice will put Teva Pharmaceuticals in grave danger by pursuing more than $10 billion at an impending False Claims Act trial, amplifying the need for immediate First...To view the full article, register now.
Already a subscriber? Click here to view full article